Big Gaps In Vaccination Supplies Highlighted In Whistleblower Complaint; Will RAPID Partnership Save The Day?
Ousted BARDA chief says HHS leaders ignored his warnings that the US lacks the necessary supplies of needles and syringes to administer a widespread COVID-19 vaccination campaign, and it could take the country two years to have enough supplies. A new public-private partnership announced in March is working to fill in those gaps.
You may also be interested in...
As COVID-19 Response Capacity Loans Languish, DFC Punts GAO’s Questions About It To DOD, HHS
Loan program launched in June 2020 to strengthen domestic supply chains for COVID-19 response was deluged with applications, but has not completed any loans, and the GAO has a good idea why.
Coronavirus Notebook: Remdesivir Supply Dwindles; US FDA Signs Another RWE Deal; Corning Gets BARDA Contract For Glass Vials
Dispatches from a world turned upside down also include changes in drug sample distribution guidelines and further reductions in the hours of FDA’s COVID hotline.
Trump’s ‘Warp Speed’ Initiative Could Fund 3 to 5 Large-Scale COVID Vaccine Trials
FDA’s Peter Marks and Janet Woodcock will be on the bridge for Operation Warp Speed; Moncef Slaoui says early clinical data on one vaccine candidate makes him confident that a few hundred million doses of a vaccine can be available by the end of the year.